MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Int J Epidemiol. 2020 Apr 1;49(2):587-596. doi: 10.1093/ije/dyz235.
Prostate cancer is the second most common male cancer worldwide, but there is substantial geographical variation, suggesting a potential role for modifiable risk factors in prostate carcinogenesis.
We identified previously reported prostate cancer risk factors from the World Cancer Research Fund (WCRF)'s systematic appraisal of the global evidence (2018). We assessed whether each identified risk factor was causally associated with risk of overall (79 148 cases and 61 106 controls) or aggressive (15 167 cases and 58 308 controls) prostate cancer using Mendelian randomization (MR) based on genome-wide association-study summary statistics from the PRACTICAL and GAME-ON/ELLIPSE consortia. We assessed evidence for replication in UK Biobank (7844 prostate-cancer cases and 204 001 controls).
WCRF identified 57 potential risk factors, of which 22 could be instrumented for MR analyses using single nucleotide polymorphisms. For overall prostate cancer, we identified evidence compatible with causality for the following risk factors (odds ratio [OR] per standard deviation increase; 95% confidence interval): accelerometer-measured physical activity, OR = 0.49 (0.33-0.72; P = 0.0003); serum iron, OR = 0.92 (0.86-0.98; P = 0.007); body mass index (BMI), OR = 0.90 (0.84-0.97; P = 0.003); and monounsaturated fat, OR = 1.11 (1.02-1.20; P = 0.02). Findings in our replication analyses in UK Biobank were compatible with our main analyses (albeit with wide confidence intervals). In MR analysis, height was positively associated with aggressive-prostate-cancer risk: OR = 1.07 (1.01-1.15; P = 0.03).
The results for physical activity, serum iron, BMI, monounsaturated fat and height are compatible with causality for prostate cancer. The results suggest that interventions aimed at increasing physical activity may reduce prostate-cancer risk, although interventions to change other risk factors may have negative consequences on other diseases.
前列腺癌是全球第二大常见男性癌症,但存在着显著的地域差异,这表明可改变的风险因素在前列腺癌的发生中可能起到一定作用。
我们从世界癌症研究基金会(WCRF)对全球证据的系统评估(2018 年)中确定了先前报道的前列腺癌风险因素。我们使用基于 PRACTICAL 和 GAME-ON/ELLIPSE 联盟全基因组关联研究汇总统计数据的孟德尔随机化(MR)方法,评估了每个已确定的风险因素是否与总体(79148 例病例和 61106 例对照)或侵袭性(15167 例病例和 58308 例对照)前列腺癌的风险相关。我们评估了 UK Biobank(7844 例前列腺癌病例和 204001 例对照)中的复制证据。
WCRF 确定了 57 个潜在的风险因素,其中 22 个可以使用单核苷酸多态性进行 MR 分析。对于总体前列腺癌,我们发现以下风险因素的证据与因果关系相符(每标准差增加的比值比[OR];95%置信区间):加速度计测量的身体活动,OR=0.49(0.33-0.72;P=0.0003);血清铁,OR=0.92(0.86-0.98;P=0.007);体重指数(BMI),OR=0.90(0.84-0.97;P=0.003);和单不饱和脂肪,OR=1.11(1.02-1.20;P=0.02)。我们在 UK Biobank 中的复制分析结果与主要分析结果一致(尽管置信区间较宽)。在 MR 分析中,身高与侵袭性前列腺癌风险呈正相关:OR=1.07(1.01-1.15;P=0.03)。
身体活动、血清铁、BMI、单不饱和脂肪和身高的结果与前列腺癌的因果关系相符。这些结果表明,旨在增加身体活动的干预措施可能会降低前列腺癌的风险,但改变其他风险因素的干预措施可能会对其他疾病产生负面影响。